Comparison of commercial one-dose and two-dose baculovirus-expressed porcine circovirus type 2 subunit vaccines
Hwi Won Seo, DVM, PhD; Jeehoon Lee, MS; Changhoon Park, DVM; Hee Jeong Kim, MS; Tae-Kyung Kwak, MS; Sung-Hoon Kim, PhD; Chanhee Chae, DVM, PhD
Complete article is available online.
PDF version is available online.
One- and two-dose recombinant porcine circovirus type 2 (PCV2) vaccines did not differ significantly in terms of immunological testing (neutralizing antibody titers, number of interferon-γ-secreting cells), virological testing (number of PCV2 genomic copies per mL serum), and pathological evidence of infection (lymphoid lesions scores and PCV2 antigen-positive cells).
Keywords: porcine circovirus type 2, porcine circovirus type 2 vaccine, PCV2
Cite as: Seo HW, Lee J, Park C, et al. Comparison of commercial one-dose and two-dose baculovirus-expressed porcine circovirus type 2 subunit vaccines. J Swine Health Prod 2014;22(6):291-295.
Search the AASV web site for pages with similar keywords.